EARNINGS: GENinCode loss narrows; Billington sales and profit jump
29th Sep 2026 15:30
(Alliance News) - The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
| Price | 0.625p on 13-10-2026 at 18:35:06 |
|---|---|
| Change | 0.00p 0% |
| Buy | 0.65p |
| Sell | 0.60p |
| Last Trade: | Buy 100.00 at 0.638p |
| Day's Volume: | 220,851 |
| Last Close: | 0.625p |
| Open: | 0.625p |
| ISIN: | GB00BL97B504 |
| Day's Range | 0.625p - 0.625p |
| 52wk Range: | 0.588p - 4.25p |
| Market Capitalisation: | £4.71m |
| VWAP: | 0.603698p |
| Shares in Issue: | 753.04m |
Sector: Medical Services
Listed In: FTSE AIM All-Share,
Genincode (GENI) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Buy* | 100 | 0.638p | Ordinary |
14:58:41 - 13-Oct-26 |
| Buy* | 2,532 | 0.65p | SI Trade |
14:55:35 - 13-Oct-26 |
| Buy* | 32 | 0.638p | Ordinary |
14:49:53 - 13-Oct-26 |
| Buy* | 3,134 | 0.638p | Ordinary |
12:59:51 - 13-Oct-26 |
| Sell* | 14,113 | 0.6007p | Ordinary |
10:26:16 - 13-Oct-26 |
| Sell* | 200,000 | 0.6026p | Ordinary |
10:24:37 - 13-Oct-26 |
| Buy* | 783 | 0.638p | Ordinary |
09:30:22 - 13-Oct-26 |
| Buy* | 20 | 0.65p | Ordinary |
09:29:10 - 13-Oct-26 |
| Buy* | 20 | 0.65p | Ordinary |
09:22:58 - 13-Oct-26 |
| Buy* | 117 | 0.638p | Ordinary |
08:34:09 - 13-Oct-26 |
Genincode (GENI) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 30th Sep 2026 4:11 pm | RNS | Holding(s) in Company |
| 29th Sep 2026 7:00 am | RNS | Half-year Financial Report |
| 22nd Sep 2026 7:00 am | RNS | Notice of Results |
| 28th Aug 2026 7:00 am | RNS | CARDIO inCode-Score milestone clinical results |
| 1st Jul 2026 1:30 pm | RNS | Result of AGM |
| 11th Jun 2026 5:42 pm | RNS | Holding(s) in Company |
| 10th Jun 2026 4:53 pm | RNS | Holding(s) in Company |
| 8th Jun 2026 7:00 am | RNS | Final Results |
| 4th Jun 2026 6:02 pm | RNS | Holding(s) in Company |
| 3rd Jun 2026 11:03 am | RNS | Holding(s) in Company |